Original article| Volume 7, ISSUE 4, P422-424, August 1993

An assessment of the duration of cephapirin-induced coagulation abnormalities as measured by thromboelastography

      This paper is only available as a PDF. To read, Please Download here.


      Cephalosporin antibiotics are used prophylactically in cardiothoracic surgery to prevent postoperative infection. In 30 patients undergoing primary elective coronary artery bypass grafting, the whole blood coagulation system was prospectively evaluated before, and 10 and 30 minutes after administration of 1 g of cephapirin (Cefadyl, Bristol Laboratory, Evansville, IN). All patients had normal preoperative coagulation studies and had not received anticoagulant or antiplatelet therapy within 7 days of surgery. At 10 minutes after cephapirin administration, 23 of 30 patients had a significant change in all phases of whole blood coagulation as monitored by thromboelastography (TEG). Thirty minutes after cephapirin administration there was no statistical difference compared with the baseline TEG. It is concluded that cephapirin can cause a significant but transient change in the viscoelastic properties of blood. Coagulation parameters of the TEG should be measured prior to cephapirin administration to prevent errors in establishing baseline values prior to cardiopulmonary bypass.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Cardiothoracic and Vascular Anesthesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Locicero J.
        Prophylactic antibiotic usage in cardiothoracic surgery.
        Chest. 1990; 98: 719-723
        • Doebbeling B.N.
        • Pfaller M.A.
        • Kuhn K.R.
        • et al.
        Cardiovascular surgery prophylaxis: A randomized, controlled comparison of cefazolin and cefuroxime.
        J Thorac Cardiovasc Surg. 1990; 99: 981-989
        • Sattler F.R.
        • Weltekamp M.R.
        • Sayegh A.
        • et al.
        Impaired hemostasis caused by beta-lactam antibiotics.
        Am J Surg. 1988; 155: 30-39
        • Tuman K.J.
        • Spiess B.D.
        • McCarthy R.J.
        • Ivankovich A.D.
        Comparison of viscoelastic measures of coagulation after cardiopulmonary bypass.
        Anesth Analg. 1989; 69: 69-75
        • Frick P.G.
        • Riedler G.
        • Borgli H.
        Dose response and minimal daily requirement for vitamin K in man.
        J Appl Physiol. 1967; 23: 387-389
        • Andrassy K.
        • Koderisch J.
        • Fritz S.
        • et al.
        Alteration of hemostasis associated with cefoperazone treatment.
        Infection. 1986; 14: 27-31
        • Shattil S.J.
        • Bennett J.S.
        • McDonough M.
        • et al.
        Carbenicillin and penicillin G inhibit platelet function in vitro by impairing the interaction of agonists with the platelet surface.
        J Clin Invest. 1980; 65: 329-337
        • Weitekamp M.R.
        • Aber R.C.
        Prolonged bleeding times and bleeding diathesis associated with moxalactam administration.
        JAMA. 1983; 249: 69-71
        • Brown R.B.
        • Klar J.
        • Lemeshow S.
        • et al.
        Enhanced bleeding with cefoxitin and moxalactam.
        Arch Intern Med. 1986; 146: 2159-2164